NDC 54092-477 – Mydayis
Dextroamphetamine Sulfate 12.5 mg/1; Dextroamphetamine Saccharate 12.5 mg/1; Amphetamine Aspartate Monohydrate 12.5 mg/1; Amphetamine Sulfate 12.5 mg/1 · Capsule, Extended Release · Oral
Product NDC54092-477
Product details
- Brand name
- Mydayis
- Generic name
- DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA022063
- Marketed since
- June 20, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant
Active ingredients
- Dextroamphetamine Sulfate 12.5 mg/1
- Dextroamphetamine Saccharate 12.5 mg/1
- Amphetamine Aspartate Monohydrate 12.5 mg/1
- Amphetamine Sulfate 12.5 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 54092-477-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-477-01) | Jun 20, 2017 |
Other Mydayis products
- 54092-468 Dextroamphetamine Sulfate 3.125 mg/1; Dextroamphetamine Saccharate… · Capsule, Extended Release · Takeda Pharmaceuticals America, Inc.
- 54092-471 Dextroamphetamine Sulfate 6.25 mg/1; Dextroamphetamine Saccharate… · Capsule, Extended Release · Takeda Pharmaceuticals America, Inc.
- 54092-474 Dextroamphetamine Sulfate 9.375 mg/1; Dextroamphetamine Saccharate… · Capsule, Extended Release · Takeda Pharmaceuticals America, Inc.